The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 29.50
Bid: 29.00
Ask: 30.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.448%)
Open: 29.50
High: 29.50
Low: 28.40
Prev. Close: 29.50
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

29 Nov 2018 07:00

RNS Number : 8321I
Ilika plc
29 November 2018
 

Ilika plc

("Ilika" and the "Company")

 

Directorate Change

Formation of Technology Advisory Board

 

Ilika plc (AIM: IKA), the advanced solid-state battery technology company, announces the appointment of Keith Jackson as Chairman from the 1st January 2019, when Mike Inglis will step down from the Board.

 

Keith Jackson has been a Non-Executive Director of Ilika since 2014 and is also currently Chief Technology Officer at Meggitt plc, where he is responsible for technology direction and strategy. Keith has had a wide-ranging and successful career in companies varying from start-ups to multinationals. He founded and as CEO grew automotive control systems company Pi Technology. Following the successful sale of the company to Ford, he joined Rolls Royce plc and became Chief Technology Officer in the electrical power and control systems group. Keith is a Fellow of the Society of Automotive Engineers and is a graduate from University College London.

 

Mike Inglis was appointed a Non-Executive Director of Ilika in July 2015 and Chairman in September 2015. He has chosen the completion of a three-year period as Chairman to step down for capacity reasons following increased committee activities on his other boards. Mike will remain involved with Ilika and become the founding member of Ilika's Technology Advisory Board, a team of industry experts to advise on the commercialisation of Ilika's technology with specialist sector knowledge.

 

Graeme Purdy, CEO, stated: "We are very grateful to Mike for the direction he has given the Ilika board over the past three years. He has assisted greatly in setting up the commercial framework we have established for bringing our Stereaxâ technology to market. I am delighted that Mike has agreed to be the founding member of Ilika's Technology Advisory Board, which will be used to contribute to Ilika's strategic direction in the coming years."

 

Mike Inglis, Chairman, added: "I have been impressed with the commercial and technical progress achieved by Ilika during my period as Chairman and I am pleased to hand over to Keith, who provides strategic continuity and brings a wealth of commercial experience, international technology and manufacturing experience to guide Ilika in its next phase."

 

Keith Jackson, Chairman elect, added: "I am delighted to accept the opportunity to guide Ilika's board as we take the Company into its next phase of commercial exploitation."

 

For more information contact:

 

Ilika plc

 

www.ilika.com

 

 

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Liberum Capital Limited

Tel: 020 3100 2000

Andrew Godber, Cameron Duncan

Trystan Cullen, William Hall

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780 / ilika@walbrookpr.com

Paul Cornelius

Mob: 07866 384 707

Lianne Cawthorne

Mob: 07584 391 303

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADMMZMRRVGRZM
Date   Source Headline
26th Apr 20247:00 amRNSAgratas joins Goliath industrialisation programme
23rd Apr 20247:00 amRNSCapital Markets Day and Trading Update
27th Mar 20247:00 amRNSNotice of Capital Markets Day and Investor Q&A
23rd Jan 20247:00 amRNSHalf-year Report
15th Jan 20247:00 amRNS2024 Conference Schedule
14th Dec 20231:46 pmRNSAward of Share Options, Exercise of Options & TVR
13th Dec 20231:43 pmRNSHolding(s) in Company
6th Dec 20237:00 amRNSLithium-ion parity development milestone
24th Nov 20237:00 amRNSTrading Update, Notice of Results & Presentations
20th Nov 20237:00 amRNSKey Technology Development Milestone
9th Oct 20237:00 amRNSAward of Scale-up Grant Funding for Goliath
20th Sep 20233:20 pmRNSResult of AGM & Award of Executive Share Options
18th Aug 20237:00 amRNSPosting of Annual Report and Notice of AGM
4th Aug 20237:00 amRNSSigned agreement with Cirtec Medical
13th Jul 20237:00 amRNSFinal Results
16th Jun 20237:00 amRNSSenior appointment&conversion of preference shares
22nd May 20237:00 amRNSTrading Update & Notice of Results
11th May 20237:00 amRNSFirst Customer Shipments of Stereax M300 Batteries
26th Apr 20237:00 amRNSExercise of Options and Total Voting Rights
11th Apr 20237:00 amRNSFirst Customer Shipment of Stereax® Batteries
8th Mar 20234:35 pmRNSPrice Monitoring Extension
1st Mar 20237:00 amRNSAward of Share Options
31st Jan 202310:30 amRNSDirector/PDMR Shareholding
30th Jan 20232:05 pmRNSSecond Price Monitoring Extn
30th Jan 20232:00 pmRNSPrice Monitoring Extension
30th Jan 202311:05 amRNSSecond Price Monitoring Extn
30th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20232:05 pmRNSSecond Price Monitoring Extn
26th Jan 20232:00 pmRNSPrice Monitoring Extension
26th Jan 202311:05 amRNSSecond Price Monitoring Extn
26th Jan 202311:00 amRNSPrice Monitoring Extension
26th Jan 20239:05 amRNSSecond Price Monitoring Extn
26th Jan 20239:00 amRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSAward of Grant Funding for Goliath
19th Jan 20237:00 amRNSHalf-year Report
16th Jan 20237:00 amRNSMOU signed with Cirtec Medical
9th Jan 20234:40 pmRNSSecond Price Monitoring Extn
9th Jan 20234:35 pmRNSPrice Monitoring Extension
28th Dec 20224:40 pmRNSSecond Price Monitoring Extn
28th Dec 20224:35 pmRNSPrice Monitoring Extension
28th Dec 20222:05 pmRNSSecond Price Monitoring Extn
28th Dec 20222:00 pmRNSPrice Monitoring Extension
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20224:40 pmRNSSecond Price Monitoring Extn
16th Dec 20224:35 pmRNSPrice Monitoring Extension
21st Nov 20221:29 pmEQSIlika 'well positioned' to deliver battery product combination
17th Nov 20224:40 pmRNSSecond Price Monitoring Extn
17th Nov 20224:35 pmRNSPrice Monitoring Extension
17th Nov 20229:05 amRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.